Atypical forms of incontinentia pigmenti in male individuals result from mutations of a cytosine tract in exon 10 of NEMO (IKK-gamma).
Familial incontinentia pigmenti (IP [MIM 308310]), or Bloch-Sulzberger syndrome, is an X-linked dominant and male-lethal disorder. We recently demonstrated that mutations in NEMO (IKK-gamma), which encodes a critical component of the NF-kappaB signaling pathway, were responsible for IP. Virtually all mutations eliminate the production of NEMO, causing the typical skewing of X inactivation in female individuals and lethality in male individuals, possibly through enhanced sensitivity to apoptosis. Most mutations also give rise to classic signs of IP, but, in this report, we describe two mutations in families with atypical phenotypes. Remarkably, each family included a male individual with unusual signs, including postnatal survival and either immune dysfunction or hematopoietic disturbance. We found two duplication mutations in these families, at a cytosine tract in exon 10 of NEMO, both of which remove the zinc (Zn) finger at the C-terminus of the protein. Two deletion mutations were also identified in the same tract in additional families. However, only the duplication mutations allowed male individuals to survive, and affected female individuals with duplication mutations demonstrated random or slight skewing of X inactivation. Similarly, NF-kappaB activation was diminished in the presence of duplication mutations and was completely absent in cells with deletion mutations. These results strongly indicate that male individuals can also suffer from IP caused by NEMO mutations, and we therefore urge a reevaluation of the diagnostic criteria.
Aradhya
S
S
Department of Molecular & Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA.
Courtois
G
G
Rajkovic
A
A
Lewis
R A
RA
Levy
M
M
Israël
A
A
Nelson
D L
DL
D000595:Amino Acid Sequence; D001483:Base Sequence; D002352:Carrier Proteins; D002869:Chromosome Aberrations; D003596:Cytosine; D005091:Exons; D005260:Female; D006801:Humans; D051550:I-kappa B Kinase; D007184:Incontinentia Pigmenti / Q000201:enzymology / Q000235:genetics*; D008297:Male; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics*; D008969:Molecular Sequence Data; D010375:Pedigree; D010641:Phenotype; D017384:Sequence Deletion; D014960:X Chromosome
D002352:Carrier Proteins; C491731:IKBKG protein, human; D003596:Cytosine; D051550:I-kappa B Kinase; D020928:Mitogen-Activated Protein Kinases